Mirae Asset Global ETFs Holdings’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
VCM
DCM
ES
Mirae Asset Global ETFs Holdings's IMNM Position: Q1 2026 in Review
Mirae Asset Global ETFs Holdings increased its Immunome (IMNM) stake by 18% in Q1 2026, buying an estimated $196K and bringing the position to 58,962 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1409.
Mirae Asset Global ETFs Holdings first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.
- Mirae Asset Global ETFs Holdings held 58,962 shares of Immunome worth $1.26M as of Q1 2026.
- Mirae Asset Global ETFs Holdings bought 8,825 Immunome shares in Q1 2026, an estimated $196K.
- Immunome made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1409 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
- 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.